NYSE:RFL Rafael Q4 2025 Earnings Report $1.93 -0.09 (-4.65%) Closing price 09/24/2026 03:58 PM EasternExtended Trading$1.91 -0.02 (-0.83%) As of 07:31 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Rafael EPS ResultsActual EPS-$0.28Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ARafael Revenue ResultsActual Revenue$0.89 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ARafael Announcement DetailsQuarterQ4 2025Date10/29/2025TimeAfter Market ClosesConference Call DateWednesday, October 29, 2025Conference Call Time5:00PM ETUpcoming EarningsRafael's Q4 2026 earnings is estimated for Wednesday, October 28, 2026, based on past reporting schedulesConference Call ResourcesPress Release (8-K)Annual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsEarnings Release(8-K)Annual Report(10-K) Rafael Earnings HeadlinesANI Pharmaceuticals (NASDAQ:ANIP) & Rafael (NYSE:RFL) Head to Head ContrastSeptember 15, 2026 | americanbankingnews.comRafael Holdings Inc Share Price (RFL.US)July 15, 2026 | lse.co.ukThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.September 25 at 1:00 AM | Chaikin Analytics (Ad)Rafael Holdings Insider Trading Activity | NYSE:RFL | BenzingaJuly 2, 2026 | benzinga.comRafael Holdings: The Second Half Of Calendar 2026 Could Define This Company ForeverJune 29, 2026 | seekingalpha.comRafael Holdings (NYSE:RFL) Stock, Short Interest ReportJune 25, 2026 | benzinga.comSee More Rafael Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Rafael? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rafael and other key companies, straight to your email. Email Address About RafaelRafael (NYSE:RFL) is a diversified holding company focused primarily on commercial real estate and life sciences. The company’s real estate activities include ownership and management of commercial properties, with a focus on properties in the New York metropolitan area and other strategic locations. Through its life sciences investments and subsidiaries, Rafael Holdings has supported the development of oncology treatments and other pharmaceutical technologies. Its best-known biotechnology subsidiary, Rafael Pharmaceuticals, developed investigational cancer therapies, including devimistat, a treatment designed to target cancer-cell metabolism. These programs have been evaluated in clinical studies, although investigational products remain subject to regulatory approval and may not become commercially available. Rafael Holdings was established following the separation of certain assets from IDT Corporation. The company is associated with entrepreneur Howard S. Jonas, who has played a significant leadership role in its development. Its operations and investments span commercial real estate and biotechnology, with activities primarily connected to the United States.View Rafael ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks3 Restaurant Stocks Near 52-Week Lows as Consumer Pressure BuildsPaychex Plunges, Providing the Entry Investors Have Been Waiting ForThe Case for Buying High-Yield General Mills Just StrengthenedDave’s Success Has Investors SplitEnergy Transfer Taps the AI Power BoomFull Throttle: Kratos and GE Fire Up a Next-Gen Defense Engine Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
